ResMed will sell its MatrixCare business for $490 million to private equity firm Frazier Healthcare Partners, according to a press release on July 8, 2026.[3195296] The sale is expected to allow ResMed to shift more resources to faster-growing parts of its portfolio.[3195296] Private equity firms are increasingly using joint ventures with nonprofits to expand in the healthcare sector, according to a report from the Private Equity Stakeholder Project.[3059062] The investment firms are looking to leverage the nonprofit-joint venture model to increase their presence in the healthcare sector.[3059062] However, there have been concerns about the lack of oversight in these joint ventures.[3059062]